This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Accuredit Therapeutics (Suzhou) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Huanle Liu: Innovator in Base Editing Technologies
Introduction
Huanle Liu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly in the area of base editing technologies. His work focuses on developing innovative tools that can modify nucleobase sequences with precision.
Latest Patents
Huanle Liu holds 1 patent for his invention titled "Deaminases and variants thereof for use in base editing." This patent provides a comprehensive overview of adenosine deaminases and their variants, which are essential components in nucleobase editors. The invention includes compositions comprising these editors and outlines methods for generating modifications in target nucleobase sequences.
Career Highlights
Huanle Liu is currently associated with Accuredit Therapeutics (Suzhou) Co., Ltd., where he continues to advance his research in genetic editing technologies. His work has positioned him as a key figure in the development of innovative solutions for genetic modifications.
Collaborations
Huanle Liu collaborates with notable colleagues, including Feifei Duan and Fuxin Shi. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Huanle Liu's contributions to base editing technologies exemplify the impact of innovative research in genetic engineering. His work not only advances scientific understanding but also holds the potential for significant applications in various fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile